Adele Hyde 7/16/24 Adele Hyde 7/16/24 AI subject matter eligibility gets its own USPTO guidance Read More Adele Hyde 7/15/24 Adele Hyde 7/15/24 Federal Trade Commission (FTC) Disputes Pharma-Industry Patent Listings Read More Adele Hyde 7/3/24 Adele Hyde 7/3/24 The Demise of Chevron and Its (Limited) Effect at the USPTO Read More Adele Hyde 6/13/24 Adele Hyde 6/13/24 Supreme Court Upholds “Names Clause” of the Lanham Act in a High- Profile Trademark Case Read More Adele Hyde 6/13/24 Adele Hyde 6/13/24 USPTO Proposed Trademark Fee Increases for 2025 Read More Adele Hyde 6/6/24 Adele Hyde 6/6/24 An Open Letter to the United States Patent and Trademark Office Read More Newer Posts Older Posts
Adele Hyde 7/16/24 Adele Hyde 7/16/24 AI subject matter eligibility gets its own USPTO guidance Read More
Adele Hyde 7/15/24 Adele Hyde 7/15/24 Federal Trade Commission (FTC) Disputes Pharma-Industry Patent Listings Read More
Adele Hyde 7/3/24 Adele Hyde 7/3/24 The Demise of Chevron and Its (Limited) Effect at the USPTO Read More
Adele Hyde 6/13/24 Adele Hyde 6/13/24 Supreme Court Upholds “Names Clause” of the Lanham Act in a High- Profile Trademark Case Read More
Adele Hyde 6/6/24 Adele Hyde 6/6/24 An Open Letter to the United States Patent and Trademark Office Read More
